0001071739-22-000167.txt : 20220419
0001071739-22-000167.hdr.sgml : 20220419
20220419193038
ACCESSION NUMBER: 0001071739-22-000167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220415
FILED AS OF DATE: 20220419
DATE AS OF CHANGE: 20220419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BROOKS MARK J
CENTRAL INDEX KEY: 0001669691
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31826
FILM NUMBER: 22836023
MAIL ADDRESS:
STREET 1: 7700 FORSYTH BOULEVARD
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CENTENE CORP
CENTRAL INDEX KEY: 0001071739
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 041406317
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7700 FORSYTH BLVD.
CITY: ST LOUIS
STATE: MO
ZIP: 63105
BUSINESS PHONE: 3147254477
MAIL ADDRESS:
STREET 1: 7700 FORSYTH BLVD.
CITY: ST LOUIS
STATE: MO
ZIP: 63105
4
1
wf-form4_165041102057419.xml
FORM 4
X0306
4
2022-04-15
0
0001071739
CENTENE CORP
CNC
0001669691
BROOKS MARK J
7700 FORSYTH BOULEVARD
ST. LOUIS
MO
63105
0
1
0
0
EVP, Chief Information Officer
Common Stock
153755
D
Phantom Stock
0.0
2022-04-15
4
A
0
18.333
86.54
A
2022-04-15
2022-04-15
Common Stock
18.333
2129.575
D
Common Stock Option (right to buy)
81.85
2031-12-15
Common Stock
6724.0
6724
D
Ownership includes 73,245 shares of restricted stock subject to vesting requirements.
Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock.
The phantom stock was acquired by Mr. Brooks through regularly scheduled payroll contributions to the Company's deferred compensation plan.
The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Brooks' termination with the Company, or on such other date Mr. Brooks may elect.
Performance Stock Option granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if the closing price of CNC's common stock equals or exceeds $100 per share for 20 consecutive trading days following the grant date.
/s/ Christopher A. Koster (executed by attorney-in-fact)
2022-04-19